Aerie Pharmaceuticals, Inc. Operating Expenses
Aerie Pharmaceuticals, Inc. reported Operating Expenses of $40.80 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2018-05-09
- Aerie Pharmaceuticals, Inc. operating expenses for the quarter ending 2018-03-31 was $40.80M, a 60.43% increase year-over-year.
- Aerie Pharmaceuticals, Inc. operating expenses for the quarter ending 2017-12-31 was $60.31M, a 109.74% increase year-over-year.
- Aerie Pharmaceuticals, Inc. operating expenses for the quarter ending 2017-09-30 was $32.18M, a 38.03% increase year-over-year.
- Aerie Pharmaceuticals, Inc. operating expenses for the quarter ending 2017-06-30 was $27.77M, a 22.38% increase year-over-year.
- Aerie Pharmaceuticals, Inc. operating expenses for fiscal 2017 was $145.69M, a 50.40% increase from fiscal 2016.
- Aerie Pharmaceuticals, Inc. operating expenses for fiscal 2016 was $96.87M, a 29.01% increase from fiscal 2015.
- Aerie Pharmaceuticals, Inc. operating expenses for fiscal 2015 was $75.09M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2018-03-31 | $40.80M 10-Q · filed 2018-05-09 | $101.11M derived: sum of 2 quarters · filed 2018-05-09 | $133.29M derived: sum of 3 quarters · filed 2018-05-09 | $161.06M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-12-31 | $60.31M 10-K · filed 2018-03-01 | $92.50M derived: sum of 2 quarters · filed 2018-03-01 | $120.26M derived: sum of 3 quarters · filed 2018-03-01 | $145.69M 10-K · filed 2018-03-01 |
| 2017-09-30 | $32.18M 10-K · filed 2018-03-01 | $59.95M derived: sum of 2 quarters · filed 2018-03-01 | $85.38M 10-Q · filed 2017-11-09 | $114.14M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-06-30 | $27.77M 10-K · filed 2018-03-01 | $53.20M 10-Q · filed 2017-08-03 | $81.95M derived: sum of 3 quarters · filed 2018-05-09 | $105.27M derived: sum of 4 quarters · filed 2018-05-09 |
| 2017-03-31 | $25.43M 10-Q · filed 2018-05-09 | $54.19M derived: sum of 2 quarters · filed 2018-05-09 | $77.50M derived: sum of 3 quarters · filed 2018-05-09 | $100.19M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | $28.76M 10-K · filed 2018-03-01 | $52.07M derived: sum of 2 quarters · filed 2018-03-01 | $74.76M derived: sum of 3 quarters · filed 2018-03-01 | $96.87M 10-K · filed 2018-03-01 |
| 2016-09-30 | $23.32M 10-K · filed 2018-03-01 | $46.01M derived: sum of 2 quarters · filed 2018-03-01 | $68.11M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $22.69M 10-K · filed 2018-03-01 | $44.80M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $22.11M 10-K · filed 2018-03-01 | |||
| 2015-12-31 | $75.09M 10-K · filed 2018-03-01 |